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Background: Ensuring adherence to treatment and retention is important in clinical trials, particularly in remote
areas and minority groups. We describe a novel approach to improve adherence, retention and clinical review rates
of Indigenous children.
Methods: This descriptive study was nested within a placebo-controlled, randomised trial (RCT) on weekly azithromycin
(or placebo) for 3-weeks. Indigenous children aged ≤24-months hospitalised with acute bronchiolitis were recruited from
two tertiary hospitals in northern Australia (Darwin and Townsville). Using mobile phones embedded within a
culturally-sensitive approach and framework, we report our strategies used and results obtained. Our main outcome
measure was rates of adherence to medications, retention in the RCT and self-presentation (with child) to clinic for a
clinical review on day-21.
Results: Of 301 eligible children, 76 (21%) families declined participation and 39 (13%) did not have access to a mobile
phone. 186 Indigenous children were randomised and received dose one under supervision in hospital. Subsequently,
182 (99%) children received dose two (day-7), 169 (93%) dose three (day-14) and 180 (97%) attended their clinical
review (day-21). A median of 2 calls (IQR 1–3) were needed to verify adherence. Importantly, over 97% of children
remained in the RCT until their clinical endpoint at day-21.
Conclusions: In our setting, the use of mobile phones within an Indigenous-appropriate framework has been an
effective strategy to support a clinical trial involving Australian Indigenous children in urban and remote Australia.
Further research is required to explore other applications of this approach, including the impact on clinical outcomes.
Trial registration: ACTRN12608000150347 (RCT component).
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In the Northern Territory (NT), Indigenous children
have high hospitalisation rates of bronchiolitis (352 per
1000) and more severe disease. Most children admitted
are retrieved from remote communities [1,2]. Hospitalised
episodes of lower respiratory infections are associated with
later development of chronic lung disease [3,4]. In an
attempt to improve clinical outcomes, we conducted a
double blind randomised controlled trial (RCT) (using* Correspondence: gabrielle.mccallum@menzies.edu.au
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unless otherwise stated.azithromycin) [5] within an evidence-based framework
for assessing and prioritising health interventions. RCTs
are accepted as the highest level of evidence available.
However, the lack of appropriate RCTs may contribute
to poor participation, attrition and treatment inequalities
in minority groups [6]. While some progress has been
made in reducing health disparities, there is a continued
need for intervention studies, both prevention and treat-
ment trials, that focus on minority population(s) [7].
There are several possible methods that can be used
to increase the adherence and reduce attrition (increase
retention) in RCTs. One such method is the use of mobile
phones as a means of communication. Mobile phonesral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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require high skills to function, are easily accessible,
affordable and not restricted to computer or land line
access [8]. The number of published research using the
short message service (SMS) component of mobile phones
to evaluate a range of health conditions has increased.
However, the conditions studied have commonly focused
on adult disease surveillance and chronic diseases [9-12].
Data on SMS outcomes in paediatric conditions; [13] i.e.
acute illnesses, Indigenous populations or remote areas
are limited.
In this study, we report on a novel approach to
improve adherence, retention and clinical follow-up
post-hospitalisation in 186 Australian Indigenous children
participating in a RCT.
Methods
Study design
This study is embedded within a double-blinded, placebo-
controlled, RCT conducted at the Royal Darwin Hospital
and The Townsville Hospital between June 2010 and
September 2013. We briefly describe the RCT below as
the protocol has been published [5]. The RCT examines
the question: ‘amongst children hospitalised with acute
bronchiolitis, does azithromycin (compared to placebo)
given once/week for three doses improve clinical out-
comes?’ For this study, we describe the cohort of children
enrolled in this RCT, strategies used and results obtained in
ensuring adherence, retention and presentation to the clinic
for follow-up. The trial was approved by each institution’s
Human Research Ethics Committee and was registered
with the Australian and New Zealand Clinical Trials Regis-
ter: Clinical trials number: ACTRN12608000150347.
Study population
Children were eligible if they were Indigenous, aged ≤24
months, admitted to hospital with a clinical diagnosis
of acute bronchiolitis, recruited within 24 hours of ad-
mission. There was also a requirement for the parent to
have a mobile phone.
Recruitment and retention approach
Research nurses visited the paediatric wards twice daily to
screen recently admitted children. Only parents whose
child met eligibility criteria were approached. A summary
of our frame work is presented in Table 1. Often parents
had come to hospital in the early hours of the morning,
were sleep deprived and had not retained information
hospital staff provided. Therefore, research nurses always
provided additional education on bronchiolitis using a
pictorial-based flipchart (http://www.menzies.edu.au/page/
Resources/Bronchiolitis_Lower_respiratory_tract_infection/).
Time was spent with parents discussing the treatment and
management of bronchiolitis and what to expect postdischarge, regardless of the decision to be involved in
the RCT. This appeared to enhance relationships and
trust. Only when parents understood what bronchiolitis
was, did research nurses proceed with discussion about
the RCT. A pictorial consent flipchart was used in
conjunction with a plain language information booklet
(endorsed by the Menzies Child Health Indigenous
Reference Group), to assist in the consent process. The
time from screening to enrolment was recorded.
Once written informed consent was obtained from the
parent or guardian, children were randomised to receive
either azithromycin or placebo. The first dose was directly
supervised in hospital; the remaining two doses were
supervised by research nurses (urban-based children)
or given at home by parents (remote-based children)
(between days 5–9 and 10–12). The endpoint was a
clinical review on day-21 (between days 20–30) by research
nurses (urban-based children) or at the local health clinic
(remote-based children) to determine presence of persistent
respiratory symptoms and signs. Remoteness was defined
as more than 100 km from a tertiary hospital.
Standardised assessment forms were used to collect
clinical information from each child. Prior to discharge,
parents were shown how to constitute the medication
and were given the remaining medications in a sealed
plastic bag which included syringes, 10 ml sterile water
vials and a fridge magnet (with reminders when each
medication and the clinical review was due).
We advised parents that we would ring or SMS when
children were due to receive the medications and attend
the clinic for their clinical review (remote-based children)
or visit at home (urban-based children). For remote-based
children, a phone call was also made to the local health
clinic explaining the child’s involvement in the RCT and
follow up required as part of routine clinical care post
hospitalisation. A template was faxed to the health clinic
and faxed back after the clinical review was completed.
The number of contacts and reasons why contact could
not be made were recorded (if applicable). A $20 mobile
recharge voucher was sent via SMS after the third dose
(but before clinical review) to thank parents for their
participation.
Other strategies used
A number of strategies were implemented to help main-
tain contact with parents throughout the RCT. Firstly,
research nurses called parent’s mobile phones prior to
discharge. This ensured the number was transcribed
correctly and started mobile phone contact while still
meeting in person. Secondly, we obtained an additional
mobile number for occasions when we were unable to
contact the parent. Thirdly, we identified that parents
would rarely answer phone calls from a blocked (un-
known) number. Research nurses therefore called from
Table 1 Framework used in our study
Pre study discussion ● Indigenous Reference Group (IRG) (consultation and endorsement of study)
● Data Safety Monitoring Board (DSMB) (endorsement of study plan)
On the ground ● Clinical Nurses with broad experience working in
● Indigenous health
Research team ● Paediatrics
● Clinical research
● Remote health settings
Project specific ● Briefings to IRG on study progress.
● DSMB updates on recruitment and retention.
● Providing education on bronchiolitis to parents using pictorial flipchart.
● Research nurses spending time discussing child’s treatment and management in hospital and home.
● Consent process: using a pictorial flipchart in conjunction with a plain language information booklet.
● Education on how to prepare, when to give medication and attend health clinic for 21 day review.
● Education to nursing staff on paediatric wards to improve awareness and understanding of bronchiolitis.
Mobile phone specific ● Calling parent in hospital (number transcribed correctly and enabled two way communication).
● Obtaining additional number (if able).
● Calling parent from personal/study mobiles.
● Providing parents with option of calling from free 1800 number.
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had the option to call research nurses on the free 1800
number if they had any questions or concerns. However,
we did not receive any call on this number. Parents pre-
ferred to call the personal mobiles of the research nurses.
Statistical analysis
Data were entered on an Access database and analysed
using Stata version 12 (Stata corp College Station, Texas,
USA). Data are presented as numbers and percentages,
median and interquartile range (IQR 25-75% and or
range). We describe feedback from parents and staff
experiences in text.
Results
Demographics
Of 301 eligible children, 76 (21%) families declined par-
ticipation and 39 (13%) did not have access to a mobile
phone. A total of 186 children were enrolled; 161 in
Darwin and 25 in Townsville. The median time taken to
enrol participants was 30 minutes (range 20 minutes –
5 hours). The median age was 5.4 months (IQR 3–9);
111 (60%) boys, and 75 (40%) girls. Four children were
withdrawn from receiving further medications (n = 3
for dose 2 and n = 4 for dose 3) by the paediatric team
at site hospitals due to other medical reasons. The
remaining children were followed up until they reached
their endpoint (day-21 clinical review). More than two
thirds of the children 144 (70%) lived in remote Indi-
genous communities. Of the Darwin-based cohort, 139
(85%) children were from remote-based communities.In contrast, only 5 (20%) children enrolled in Townsville
were remote-based. Figure 1 illustrates approximate loca-
tions of all communities and distances from site hospitals.
Medication and clinical review
All children 186 (100%) received the first dose of medi-
cation in hospital. A small number of children received
dose-2 (n = 17 (8%)) and dose-3 (n = 3 (1%)) in hospital.
For the remainder, research nurses made contact with
parents on their mobiles when medication(s) and the
clinic review were due. The adherence, retention and
follow-up rate for the entire cohort was very high. Over-
all, 182 (99%) children received dose two (day-7), 169
(93%) received dose three (day-14) and 180 (97%) children
attended their day-21 clinical review. Table 2 summarises
the number of medication doses received, clinic reviews
attended, missed and the median number of phone calls
required to contact the carer.
For dose-2, 62% of parents were able to be contacted
on the first attempt; this reduced to 39% by dose-3 and
18% for the clinical review (Figure 2). However, only a
small number of calls were needed to verify when medi-
cation(s) and the clinical review were completed (median
2 calls (IQR 1–3)). Reasons for calls not being taken were
most frequently due to (i) mobile phones being turned off;
(ii) mobile phones not charged; or (iii) parents not answer-
ing a call from a blocked (private) number.
Discussion
In our setting, it appears that mobile phones, combined
with a culturally sensitive approach, were a simple and
Figure 1 Map of communities. NB: Some communities appear to be located in the ocean, however are Islands north of the mainland.
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To our knowledge, this is the first RCT involving Indigen-
ous children that has used mobile phones to support
adherence to research protocols. The success of our
strategies is documented by a 97% retention rate, the
highest we have ever achieved in a setting that involved
children in the community.
The use of mobile phones in studies is not new. Previous
research has shown mobile phones can have important
benefits for clinic attendance, adherence to medications
and treatment plans [14-17]. However we found only 3
studies involving children and none were relevant to
Indigenous Australians or in acute illnesses [13,18,19]
Two of the 3 studies related to immunisations, [13,18]
and the third was on reminders for appointments before
and after cataract surgery in a large Chinese city hospital
[19]. Two studies reported an improvement in the
intervention group, compared to controls 43% vs. 39.9%Table 2 Medication doses and clinic review by site
Trial procedures Darwin
Given
(n = 161)
Missed
N (%)
Number c
median (r
Dose 1 161 (100%) 0 (0%) N/A
Dose 2* 157 (98%) 4 (2%) 1 (1–1
Dose 3* 147 (91%) 14 (9%) 2 (1–1
Clinical review 156 (97%) 5 (3%) 3 (1–1
*3 children withdrawn from dose 2, 4 children withdrawn from dose 3 by the medi
#Combination of phone calls/SMS.[18] and 91% vs. 62% respectively [19]. The third study
reported similar adherence in both groups using an
intention to treat analysis 66% vs. 68% [13]. In contrast
to the above studies, our study is not a RCT on mobile
phones but a unique report on how we achieved an
exceptional high retention and follow-up rate in a study
setting where adherence to medications and follow-up
has been reported to be generally difficult. While we
were unable to observe adherence with doses 2 and 3
for remote-based children (we were reliant on parents
providing this information), the day-21 follow-up rate
of >97% at the local health clinic provides evidence of
the success of our approach.
Including minorities in RCTs is important in addressing
health gaps [20]. Adherence has been reported to be
particularly challenging in those who are socially disad-
vantaged communities [7]. Improving adherence and
reducing attrition is important in all clinical trials.Townsville
ontacts
ange)#
Given
(n = 25)
Missed
N (%)
Number contacts
median (range)
25 (100%) 0 (0%) N/A
2) 25 (100%) 0 (0%) 2 (1–5)
3) 22 (88%) 3 (12%) 2 (1–6)
7) 24 (96%) 1 (4%) 3 (1–7)
cal team.
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Figure 2 Number of contacts medication dose and clinical follow up.
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power and generalisability of results [21]. Our study has
also shown that adherence to medications in the commu-
nity setting is feasible, thus the opportunity for community
based clinical care and follow-up can be highly successful.
In addition to our mobile phone strategies, appropriate
measures include: (i) building relationships and trust with
parents; (ii) using culturally appropriate educational mater-
ial; and (iii) personal contact with parents. It may also be
important that all research staff were paediatric-trained
with experience in working with Indigenous parents and
children.
Our mobile phone strategy not only included obtaining
multiple phone numbers but also calling from a mobile
that displayed a number that could be identified by the
parent. Over the past 14 years, network coverage in
remote Australia has substantially improved. A study in
the NT reported that mobile phones have become an
essential part of relaying information to family members
who were travelling or away from home [22].
Our strategies and findings have to be interpreted in
the context of our target population and study settings.
We recruited only children whose parents had a mobile
phone as geographical remoteness limited our options to
ascertain adherence. Although we did not expect the
high number of mobile phone ownership, we found that
only a small number of parents (13%) did not have access
to a mobile phone at time of recruitment. It was not
feasible for us to request community health clinics to
supervise medication dosing as most of the childrencome from remote clinics with very high workloads.
The clinical review was attended by health clinic staff
as part of best practice guidelines for routine clinical
care post hospitalisation for a respiratory infection in
Australia and many affluent countries.
Families received a $20 mobile recharge voucher after
the final medication dose, to thank them for their par-
ticipation. While we provided this incentive, we do not
feel this was fundamental to the adherence and retention
of participants in our trial. Importantly, the incentive
was provided before the day-21 clinical review, where
the presentation rate was 97%. Previously, incentives in
clinical trials have only reported small improvements in
participant retention between 2-13% [21,23]. One RCT
involved SMS reminders and provided a $20 gift card at
time of enrolment [24]. The RCT [24] described that gift
cards were not important to 22% of participants, some-
what important in 50%, and very important to 28% with
regard to their participation in the RCT [13].
We speculate that building relationships and trust
were fundamental to our high success of adherence and
retention in this trial. In general, parents expressed how
they felt supported in hospital and at home, knowing
that our staff were there to talk to if they had queries or
concerns about their child. In our setting, displacement
to a major teaching hospital from a remote community
can be distressing for Indigenous people. The approach
used by our research nurses helped alleviate parent’s
anxiety by providing support and understanding of
bronchiolitis and thus we feel fundamental to them
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was part of our culture-appropriate framework (Table 1).
Our framework is supported by a similar strategies used to
enhance participation of Maori people in a cardiovascular-
based RCT in New Zealand. The NZ study outlined the
importance of involving experienced Maori researchers at
each time point of the trial, employing experienced Maori
researchers, who used culturally specific processes for
participation and retention of Maori participants and
ongoing contact with Maori researchers and participants
[24]. Such frameworks are important and highlight the
effectiveness of strategies that are culturally appropriate,
thus improving the participation and retention rates in
minority populations.
Within our framework, we implemented multiple strat-
egies to support adherence and retention of participants.
It is difficult to ascertain the relative contribution to these
strategies. This study was embedded within an RCT, thus
is complex with the respect to the possible interaction
between both a treatment intervention (azithromycin
or placebo) and enhancing support (implementing cultural
framework). Future treatment trials should account for
these factors. One of our study’s limitations includes the
lack of in-depth qualitative data to explore this issue. Also,
our intervention period is relatively short (3 weeks).
Whether or not these strategies will also be successful in
longer term interventions remains unknown. Although
the data presented are not high-level evidence (i.e. not a
RCT), we have shown that the use of strategies employed
here has led to an exceptionally high adherence and reten-
tion rate. This may have implications for clinical service
in remote Indigenous settings and may improve health
outcomes. It should be further studied as provision of
high quality clinical service and ensuring adherence is a
challenge in many settings, particularly in remote Indi-
genous settings.Conclusions
Our data have provided important and novel data that the
use of mobile phones, in conjunction with a culturally
sensitive approach, is an effective strategy to support clin-
ical trial protocols in Indigenous children living in urban
and remote Australia. There is an opportunity to use these
strategies to support health service delivery in remote
communities that may improve adherence to medications
and clinic attendance. Further research is required to ex-
plore the feasibility in these setting for health outcomes,
cost effectiveness and long term sustainability using our
described framework.
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